SELLAS Life Sciences
SLS
#4150
Rank
A$4.20 B
Marketcap
A$20.64
Share price
-8.08%
Change (1 day)
771.13%
Change (1 year)

Earnings for SELLAS Life Sciences (SLS)

Earnings in 2026 (TTM): -A$51.79 Million

According to SELLAS Life Sciences's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$42.72 Million, an increase over its 2024 earnings that were of -A$47.61 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for SELLAS Life Sciences from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$51.79 Million21.23%
2025 -A$42.72 Million-10.28%
2024 -A$47.61 Million-16.78%
2023 -A$57.22 Million-9.73%
2022 -A$63.38 Million65.85%
2021 -A$38.22 Million48.95%
2020 -A$25.66 Million-1.31%
2019 -A$26 Million-44.65%
2018 -A$46.97 Million45.99%
2017 -A$32.18 Million-33.17%
2016 -A$48.15 Million-6.87%
2015 -A$51.7 Million-30.98%
2014 -A$74.91 Million46.52%
2013 -A$51.13 Million
2011 -A$25.38 Million
2008 -A$21.99 Million27.51%
2007 -A$17.25 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.24 Billion 343.33%๐Ÿ‡บ๐Ÿ‡ธ USA